About
Smartlens Inc is a clinical-stage ophthalmic technology company dedicated to improving the management of anterior segment diseases, particularly glaucoma. Their flagship product, miLens, is a small wearable microfluidic soft contact lens that continuously monitors intraocular pressure (IOP), a key risk factor for glaucoma. This innovative approach allows for non-invasive tracking outside of clinical settings. In addition to miLens, Smartlens is developing Slit IQ™, an AI-enhanced platform designed for remote eye exams. This platform aims to integrate monitoring, diagnosis, and treatment into a single, accessible solution. The company holds over 40 global patents and has an exclusive license from Stanford University, supporting their mission to provide continuous, data-driven eye care. Smartlens has garnered strong interest from eyecare practitioners in the U.S. and successfully raised $6.1 million in Series A funding to advance their product development and regulatory efforts.
Technologies
Keywords
Company Information
-
Employees 14
-
Founded 2015
-
Annual Revenue $3000000
-
Total Funding $6100000
Location
1010 Stewart Dr, Sunnyvale, California, United States, 94085-3914